ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Long-Term Satisfaction with Life after Living Kidney Donation: A RELIVE Study

    E. Messersmith, B. Gillespie, B. Hong, C. Jacobs, S. Taler, S. Jowsey, R. Merion, A. Leichtman, C. Beil, C. Gross, the RELIVE Study Group

    Arbor Research Collaborative for Health; University of Michigan; Washington University; University of Minnesota; Mayo Clinic

    Background:Little is known about the long-term satisfaction with life (SWL) of live kidney donors. We surveyed SWL among a population of kidney donors participating in…
  • 2013 American Transplant Congress

    Probability of a Positive AHG-CDC Crossmatch Is Determined by the Number, Strength, and Specificity of Donor-Specific Antibodies

    J. Lan, G. Espino-Hernandez, J. Gill, P. Keown

    Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada

    Background: The factors determining the relationship between donor-specific antibodies (DSA) and the anti-human globulin complement-dependent cytotoxicity crossmatch (AHG-CDC XM) are not clearly defined. Canadian consensus…
  • 2013 American Transplant Congress

    Recipient Death and Graft Loss in Renal Transplantation: The Challenge of Infectious Complications

    M. Cristelli, M. Ivani, F. Pita, F. Ferreira, S. Martins, C. Aldworth, M. Francoso, M. Franco, H. Tedesco, J. Medina- Pestana

    Hospital do Rim e Hipertensão, Sao Paulo, Brazil

    Introduction: The causes of recipient death and renal allograft loss are still under evaluated, and there might be several differences according to the era of…
  • 2013 American Transplant Congress

    IL-33 Expands ST2+ Regulatory T Cells Promoting Allograft Survival Directly and Indirectly through Actions on Myeloid Dendritic Cells

    B. Matta, L. Mathews, B. Rosborough, H. Turnquist

    Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA; Surgery, University of Pittsburgh, Pittsburgh, PA; Immunology, University of Pittsburgh, Pittsburgh, PA

    Background: IL-33 is an IL-1 cytokine that signals via ST2, which is expressed on both T cells and myeloid cells. IL-33 has been ascribed Th2…
  • 2013 American Transplant Congress

    Results of a Phase 2 Safety, Efficacy, and Pharmacokinetic Study of TOL-101, an Anti-TCR Monoclonal Antibody for the Prophylaxis of Acute Rejection in Kidney Transplantation

    S. Flechner, S. Mulgaonkar, L. Melton, T. Waid, R. Sung, F. Shihab, A. Wiseman, D. Getts

    Cleveland Clinic Foundation, Cleveland; Barnabas Health, West Orange; Dallas Transplant Institute, Dallas Fort Worth; Tolera Therapeutics Inc, Kalamazoo; University of Kentucky, Lexington; University of Michigan, Ann Arbor; University of Utah, Salt Lake city; University of Colorado, Denver; Northwestern University, Chicago

    Purpose: Induction therapy using anti-lymphocytic antibodies is a potent tool for the prevention of early rejection after kidney transplantation. TOL-101, an IgM monoclonal antibody, with…
  • 2013 American Transplant Congress

    Thrombin Generation and Platelet Activation in a Xenogenic Lung Perfusion Model Determine Survival of GalTKO.hCD46 Transgenic Lungs

    L. Burdorf, E. Rybak, T. Zhang, A. Riner, G. Braileanu, X. Cheng, C. Phelps, D. Ayares, A. Azimzadeh, R. Pierson III

    Surgery, University of Maryland, Baltimore, MD; Revivicor, Inc., Blacksburg, VA

    Purpose: As previously reported, the development of GalTKO pigs with additional expression of hCD46 has contributed to a significantly improved outcome of lungs in an…
  • 2013 American Transplant Congress

    Blocking C3a/C5a-Receptor Signaling Promotes Induction and Stability of Murine and Human Alloreactive Regulatory T Cells

    W. van der Touw, C. Paolo, K. Wing, H. Peter

    Immunology Institute, Mount Sinai School of Medicine, New York, NY

    Adoptive transfer of CD4+Foxp3+ regulatory T cells (Treg) has potential for promoting transplantation tolerance but is limited by the scarcity of thymic-derived Treg and the…
  • 2013 American Transplant Congress

    Abnormal Distribution of B-Cell Populations Associated with Impaired Regulatory Functions in Chronic Antibody Mediated Rejection

    A. Nouël, I. Segalen, A. Grall, J. Pers, S. Hillion, Y. Le Meur

    EA2216 Immunology and Pathology, University of Brest, Brest, France; Nephrology, CHRU Cavale Blanche, Brest, France

    Chronic antibody (Ab) mediated rejection (cAMR) represents the major problem in renal transplantation. The aim of our study was to analyze B lymphocyte (LB) distribution…
  • 2013 American Transplant Congress

    Update on Phase 2 Clinical Trial To Induce Tolerance in Mismatched Living Donor Renal Transplant Recipients

    J. Leventhal, M. Abecassis, J. Miller, L. Gallon, K. Ravindra, D. Tollerud, B. King, M. Elliott, G. Herzig, R. Herzig, S. Ildstad

    Northwestern University, Chicago, IL; Institute for Cellular Therapeutics, University of Louisville, Louisville, KY; James Graham Brown Cancer Ctr, University of Louisville, Louisville, KY; Regenerex, LLC, Louisville, KY

    19 subjects have been enrolled in a phase 2 protocol (FDA IDE 13947) to induce tolerance in mismatched recipients of living donor renal allografts (KTx).…
  • 2013 American Transplant Congress

    Product of Donor Age and Preoperative MELD, D−MELD, Predicts Surgical Outcomes after LDLT in HCV Positive Recipients, but Not in HCV Negative Recipients, The

    A. Tanemura, S. Mizuno, N. Kuriyama, Y. Azumi, I. Osawa, M. Kishiwada, M. Usui, H. Sakurai, M. Tabata, S. Isaji

    Hepatobiliary-Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan

    Background:Donor age and MELD score are recognized as risk factors affecting recipient outcomes in living donor liver transplantation (LDLT). The aim of this study is…
  • « Previous Page
  • 1
  • …
  • 1582
  • 1583
  • 1584
  • 1585
  • 1586
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences